Identification of a DNA methylation episignature for recurrent constellations of embryonic malformations

The term "recurrent constellations of embryonic malformations" (RCEM) is used to describe a number of multiple malformation associations that affect three or more body structures. The causes of these disorders are currently unknown, and no diagnostic marker has been identified. Consequentl...

Full description

Saved in:
Bibliographic Details
Published in:American journal of human genetics Vol. 111; no. 8; p. 1643
Main Authors: Haghshenas, Sadegheh, Karimi, Karim, Stevenson, Roger E, Levy, Michael A, Relator, Raissa, Kerkhof, Jennifer, Rzasa, Jessica, McConkey, Haley, Lauzon-Young, Carolyn, Balci, Tugce B, White-Brown, Alexandre M, Carter, Melissa T, Richer, Julie, Armour, Christine M, Sawyer, Sarah L, Bhola, Priya T, Tedder, Matthew L, Skinner, Cindy D, van Rooij, Iris A L M, van de Putte, Romy, de Blaauw, Ivo, Koeck, Rebekka M, Hoischen, Alexander, Brunner, Han, Esteki, Masoud Zamani, Pelet, Anna, Lyonnet, Stanislas, Amiel, Jeanne, Boycott, Kym M, Sadikovic, Bekim
Format: Journal Article
Language:English
Published: United States 08-08-2024
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The term "recurrent constellations of embryonic malformations" (RCEM) is used to describe a number of multiple malformation associations that affect three or more body structures. The causes of these disorders are currently unknown, and no diagnostic marker has been identified. Consequently, providing a definitive diagnosis in suspected individuals is challenging. In this study, genome-wide DNA methylation analysis was conducted on DNA samples obtained from the peripheral blood of 53 individuals with RCEM characterized by clinical features recognized as VACTERL and/or oculoauriculovertebral spectrum association. We identified a common DNA methylation episignature in 40 out of the 53 individuals. Subsequently, a sensitive and specific binary classifier was developed based on the DNA methylation episignature. This classifier can facilitate the use of RCEM episignature as a diagnostic biomarker in a clinical setting. The study also investigated the functional correlation of RCEM DNA methylation relative to other genetic disorders with known episignatures, highlighting the common genomic regulatory pathways involved in the pathophysiology of RCEM.
ISSN:1537-6605
DOI:10.1016/j.ajhg.2024.07.005